Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DC3I7P
|
|||
Drug Name |
GSK5251738
|
|||
Indication | Hepatitis B [ICD-11: 1E51; ICD-10: B18.1] | Phase 1 | [1] | |
Company |
GlaxoSmithKline
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Toll-like receptor 8 (TLR8) | Target Info | Agonist | [1] |
KEGG Pathway | Toll-like receptor signaling pathway | |||
NetPath Pathway | Leptin Signaling Pathway | |||
TCR Signaling Pathway | ||||
Panther Pathway | Toll receptor signaling pathway | |||
Reactome | Trafficking and processing of endosomal TLR | |||
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | ||||
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | ||||
MyD88 dependent cascade initiated on endosome | ||||
WikiPathways | Toll-like receptor signaling pathway | |||
Toll-Like Receptors Cascades | ||||
MyD88 dependent cascade initiated on endosome | ||||
Trafficking and processing of endosomal TLR | ||||
Regulation of toll-like receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of GlaxoSmithKline |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.